TLR9 signaling requires ligand-induced phosphorylation of two specific tyrosine residues by EGFR and Syk

Manoj Veleeparambil,Chenyao Wang,Patricia M Kessler,Belinda Willard,Ganes C Sen,Saurabh Chattopadhyay
DOI: https://doi.org/10.1101/2024.07.03.601759
2024-07-05
Abstract:Toll-like receptors (TLRs) are transmembrane proteins required for recognizing microbial components or cellular danger signals to activate intracellular signaling pathways leading to induction of anti-microbial and inflammatory genes. Inactive TLRs require ligand-induced activation to recruit adaptor proteins, e.g., MyD88, to trigger the synthesis of cytokines and interferons. TLR9 is an endosomal membrane-bound protein, which binds to CpG-containing microbial DNA or endogenous signals from dead cells or tissue damage. We showed that TLR9 activation requires EGFR, a tyrosine (Tyr) kinase, which interacts with and phosphorylates the cytoplasmic domain of TLR9. Blocking EGFR activity pharmacologically, or knocking out EGFR gene in myeloid cells, suppressed lethal TLR9-induced hepatotoxicity. Here, we reveal that TLR9 required two Src family of kinases, Syk and Lyn, which, together with EGFR, led to phosphorylation and activation of TLR9. Lack of either of these kinases inhibited TLR9-MyD88 interaction, thereby inhibiting TLR9-mediated gene induction. Unlike EGFR, which constitutively binds TLR9, activated Syk interacted with TLR9 in a CpG-dependent manner. Activated Syk interacted with TLR9 and was critical for activating TLR9-bound EGFR. Quantitative mass spectrometric analyses revealed TLR9 was phosphorylated, sequentially, on Tyr870 and Tyr980 by Syk and EGFR, respectively. Mutation of either of these tyrosines led to complete loss of TLR9-induced cytokine production. For activation, Syk was phosphorylated by Lyn, which was activated by CpG-mediated scavenger-receptor A, and surprisingly, independent of TLR9. In summary, our results uncovered the molecular details of TLR9 activation by its Tyr-phosphorylation, which is critical for TLR9-mediated intracellular signaling.
Immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **To clarify the specific molecular mechanism of TLR9 signal transduction, especially the regulatory process of its tyrosine phosphorylation and its role in intracellular signal transduction**. ### Background and Core of the Problem Toll - like receptors (TLRs) are a class of transmembrane proteins responsible for recognizing microbial components or cellular danger signals, activating intracellular signal transduction pathways, and thus inducing the expression of antimicrobial and inflammatory genes. TLR9 is a protein located on the endosomal membrane and can bind to microbial DNA containing CpG or endogenous signals from dead cells or tissue damage. To activate TLR9, specific tyrosine residues need to be phosphorylated, a process mediated by EGFR (epidermal growth factor receptor) and Syk (spleen tyrosine kinase). ### Specific Problems 1. **The specific molecular mechanism of TLR9 activation**: Researchers have found that the activation of TLR9 requires not only the action of EGFR, but also the participation of two Src family kinases, Syk and Lyn. How these kinases work together to phosphorylate and activate TLR9 is one of the focuses of this paper. 2. **The specific sites of tyrosine phosphorylation**: Through mass spectrometry analysis, researchers have determined that two key tyrosine residues (Y870 and Y980) of TLR9 are phosphorylated by Syk and EGFR respectively. These phosphorylation events are crucial for the interaction between TLR9 and MyD88 and the induction of downstream genes. 3. **The activation mechanisms of Syk and Lyn**: The study also reveals the activation mechanisms of Syk and Lyn. The activation of Syk depends on Lyn, while the activation of Lyn is mediated by CpG - bound scavenger receptor A (SR - A), a process independent of TLR9. ### Research Significance Understanding the specific molecular mechanism of TLR9 activation, especially the regulatory process of its tyrosine phosphorylation, is helpful for in - depth understanding of the role of TLR9 in the immune response and how to control TLR9 - mediated signal transduction by regulating these kinases, thus providing new strategies for treating TLR9 - related diseases. For example, the use of EGFR inhibitors may help to reduce the hepatotoxicity caused by excessive activation of TLR9. In conclusion, through detailed experiments and analysis, this paper reveals the specific mechanism of tyrosine phosphorylation in TLR9 signal transduction, providing a theoretical basis for the treatment of related diseases.